Inotek Pharmaceuticals Announces Participation in Ophthalmology Panel at 18th Annual BIO CEO & Investor Conference on February 8th
LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek announced that David P. Southwell, President and Chief Executive Officer, will participate in an ophthalmology panel at the 18th Annual BIO CEO & Investor Conference.
